Zevra Therapeutics’ $91 Million Acquisition of Acer Therapeutics

Pietro Martinoia
Tagged:

Bryan Cave is advising Zevra, and Pillsbury is advising Acer Therapeutics.Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) and Acer Therapeutics Inc. (Nasdaq: ACER) announced the companies have entered into a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now